Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

MHC class II molecules enhance Toll-like receptor mediated innate immune responses.

Frei R, Steinle J, Birchler T, Loeliger S, Roduit C, Steinhoff D, Seibl R, Büchner K, Seger R, Reith W, Lauener RP.

PLoS One. 2010 Jan 20;5(1):e8808. doi: 10.1371/journal.pone.0008808.

2.

Evaluation of a new biodegradable membrane to prevent gingival ingrowth into mandibular bone defects in minipigs.

Thoma DS, Halg GA, Dard MM, Seibl R, Hammerle CH, Jung RE.

Clin Oral Implants Res. 2009 Jan;20(1):7-16. doi: 10.1111/j.1600-0501.2008.01604.x.

PMID:
19126102
3.

Bone apposition around two different sandblasted and acid-etched titanium implant surfaces: a histomorphometric study in canine mandibles.

Bornstein MM, Valderrama P, Jones AA, Wilson TG, Seibl R, Cochran DL.

Clin Oral Implants Res. 2008 Mar;19(3):233-41. doi: 10.1111/j.1600-0501.2007.01473.x. Epub 2008 Jan 3.

PMID:
18177427
4.

The effect of matrix bound parathyroid hormone on bone regeneration.

Jung RE, Cochran DL, Domken O, Seibl R, Jones AA, Buser D, Hammerle CH.

Clin Oral Implants Res. 2007 Jun;18(3):319-25. Epub 2007 Mar 26.

PMID:
17386063
5.

Toll-like receptors in rheumatoid arthritis joint destruction mediated by two distinct pathways.

Ospelt C, Kyburz D, Pierer M, Seibl R, Kurowska M, Distler O, Neidhart M, Muller-Ladner U, Pap T, Gay RE, Gay S.

Ann Rheum Dis. 2004 Nov;63 Suppl 2:ii90-ii91. Review. No abstract available.

6.

Pattern recognition receptors and their involvement in the pathogenesis of arthritis.

Seibl R, Kyburz D, Lauener RP, Gay S.

Curr Opin Rheumatol. 2004 Jul;16(4):411-8. Review.

PMID:
15201605
7.

Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis.

Jüngel A, Distler JH, Kurowska-Stolarska M, Seemayer CA, Seibl R, Forster A, Michel BA, Gay RE, Emmrich F, Gay S, Distler O.

Arthritis Rheum. 2004 May;50(5):1468-76.

8.

Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands.

Pierer M, Rethage J, Seibl R, Lauener R, Brentano F, Wagner U, Hantzschel H, Michel BA, Gay RE, Gay S, Kyburz D.

J Immunol. 2004 Jan 15;172(2):1256-65. Erratum in: J Immunol. 2004 Feb 15;172(4):following 2703.

9.

Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium.

Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, Saurenmann T, Michel BA, Seger RA, Gay S, Lauener RP.

Am J Pathol. 2003 Apr;162(4):1221-7.

10.

Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.

Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA, Gay S.

Arthritis Rheum. 2003 Mar;48(3):642-50.

11.

[Classification and predictive quality of the "suicide intent" marker in parasuicides. A cluster analytic study].

Antretter E, Dunkel D, Seibl R, Haring C.

Nervenarzt. 2002 Mar;73(3):219-30. German.

PMID:
11963257
12.

Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein.

Birchler T, Seibl R, Büchner K, Loeliger S, Seger R, Hossle JP, Aguzzi A, Lauener RP.

Eur J Immunol. 2001 Nov;31(11):3131-7.

13.

[Survivors of suicide victims searching for answers and ways out of the crisis].

Seibl R.

Psychiatr Prax. 2001 Oct;28(7):348-50. German. No abstract available.

PMID:
11600964
14.

[The consequences of a suicide for the bereaved - current knowledge, unresolved questions and tasks of future research].

Seibl R, Antretter E, Haring C.

Psychiatr Prax. 2001 Oct;28(7):316-22. German.

PMID:
11600956
15.

The digoxigenin (DIG) system for non-radioactive labelling and detection of nucleic acids--an overview.

Höltke HJ, Ankenbauer W, Mühlegger K, Rein R, Sagner G, Seibl R, Walter T.

Cell Mol Biol (Noisy-le-grand). 1995 Nov;41(7):883-905. Review.

PMID:
8595368
16.

Nonradioactive 3'-end-labeling of RNA molecules of different lengths by terminal deoxynucleotidyltransferase.

Rosemeyer V, Laubrock A, Seibl R.

Anal Biochem. 1995 Jan 1;224(1):446-9.

PMID:
7535988
17.

A new method for measuring reverse transcriptase activity by ELISA.

Eberle J, Seibl R.

J Virol Methods. 1992 Dec 1;40(3):347-56.

PMID:
1282132
18.

Nonradioactive in situ hybridization with digoxigenin labeled DNA probes.

Arnold N, Seibl R, Kessler C, Wienberg J.

Biotech Histochem. 1992 Mar;67(2):59-67.

PMID:
1599973
19.

Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase.

Schmitz GG, Walter T, Seibl R, Kessler C.

Anal Biochem. 1991 Jan;192(1):222-31.

PMID:
2048725
20.

Non-radioactive labeling and detection of nucleic acids. II. Optimization of the digoxigenin system.

Höltke HJ, Seibl R, Burg J, Mühlegger K, Kessler C.

Biol Chem Hoppe Seyler. 1990 Oct;371(10):929-38.

PMID:
2076200
21.
22.

Non-radioactive labeling and detection of nucleic acids. III. Applications of the digoxigenin system.

Seibl R, Höltke HJ, Rüger R, Meindl A, Zachau HG, Rasshofer R, Roggendorf M, Wolf H, Arnold N, Wienberg J, et al.

Biol Chem Hoppe Seyler. 1990 Oct;371(10):939-51.

PMID:
1963785
23.

Identification of proteins encoded by Epstein-Barr virus trans-activator genes.

Marschall M, Leser U, Seibl R, Wolf H.

J Virol. 1989 Feb;63(2):938-42.

24.

Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.

Countryman J, Jenson H, Seibl R, Wolf H, Miller G.

J Virol. 1987 Dec;61(12):3672-9.

25.
26.
28.

Benign and malignant disease caused by EBV.

Wolf H, Seibl R.

J Invest Dermatol. 1984 Jul;83(1 Suppl):88s-95s. Review.

29.

Supplemental Content

Support Center